| Ms Jennifer Ann Walters, CNM | |
|
388 W Center St, Manchester, CT 06040-4735 | |
| (860) 649-1120 | |
| (860) 645-8541 |
| Full Name | Ms Jennifer Ann Walters |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 388 W Center St, Manchester, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215287917 | NPI | - | NPPES |
| 000373 | Other | CT | LICENSE |
| 1010134298 | Other | VT | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 000373 (Connecticut) | Secondary |
| 367A00000X | Advanced Practice Midwife | 1010134298 (Vermont) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer Ann Walters, CNM 50 Timber Ter, Cary, IL 60013-1555 Ph: () - | Ms Jennifer Ann Walters, CNM 388 W Center St, Manchester, CT 06040-4735 Ph: (860) 649-1120 |
News Archive
Inactivation of a DNA repair gene may be an early step in the development of sporadic colorectal tumors, and detection of the molecular basis for this inactivation may ultimately be useful in risk assessment for colorectal cancer, according to a new study in the current issue of the Journal of the National Cancer Institute.
Delcath Systems, Inc. a development stage, specialty pharmaceutical and medical device company focused on oncology will host a conference call to discuss recent corporate developments on Tuesday, June 15, 2010 at 4:30 p.m., Eastern. Eamonn P. Hobbs, the Company's President and CEO, David McDonald, CFO, and Krishna Kandarpa, MD, Chief Medical Officer, will be on hand during the call and webcast.
Researchers recommend measuring inhibin B concentration in combination with basal luteinising hormone as a first-line test to discover the underlying cause of delayed puberty in boys.
BerGenBio AS, an oncology biopharmaceutical company, today announces that an abstract on the latest data on BGB324, the Company's first-in-class, selective small molecule inhibitor of the Axl receptor tyrosine kinase, and BGB10C9, an Axl function-blocking monoclonal antibody in pre-clinical development at BerGenBio, has been published in conjunction with the 2015 American Society of Clinical Oncology Annual Meeting in Chicago, May 29 - June 2, 2015.
Researchers from Queen's University Belfast have shown for the first time that the eye could be a surrogate for brain degeneration like Alzheimer's disease (AD).
› Verified 2 days ago
Mr. Russell S Medbery Jr., Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 360 Tolland Tpke, Suite 3b, Manchester, CT 06042 Phone: 860-646-1157 Fax: 860-646-9877 | |
Mrs. Laura Alsen Piscioneri, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 201 E Center St, Manchester, CT 06040 Phone: 860-649-6199 Fax: 860-643-2123 | |
Maura Aaberg, C.N.M., W.H.N.P. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 394 W Center St, Manchester, CT 06040 Phone: 888-607-0046 | |
Mrs. Ariel Jesse Herron, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 388 W Center St, Manchester, CT 06040 Phone: 860-649-1120 | |
Maria Diana Avellino, C.N.M. Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 388 West Center St, Manchester, CT 06040 Phone: 860-649-1120 Fax: 860-645-8541 | |
Suzanne Murphy Barton, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 192 E Center St, Manchester, CT 06040 Phone: 888-607-0046 Fax: 888-690-0088 |